Reprint
Biochemical Biomarkers and Neurodegenerative Diseases
Edited by
August 2021
156 pages
- ISBN978-3-0365-1722-3 (Hardback)
- ISBN978-3-0365-1721-6 (PDF)
This book is a reprint of the Special Issue Biochemical Biomarkers and Neurodegenerative Diseases that was published in
Biology & Life Sciences
Computer Science & Mathematics
Medicine & Pharmacology
Public Health & Healthcare
Summary
In this book, we collected scientific articles, including reviews and research articles, showcasing the lastest literature on the importance of biochemical biomarkers in the management of neurodegenerative diseases, from screening to diagnosis, prognosis, and treatment.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
GLUT3; cerebral ischemia; MCAO; resveratrol; astrocytes; AMPK; amyotrophic lateral sclerosis; GSK3β; neurodegenerative disease; PD; Arylsulfatase A; lysosomes; GWAS; Gaucher’s disease; prognostic biomarker; focused ultrasound; MR-guided focused ultrasound; high-intensity focused ultrasound ablation; magnetic resonance imaging; image quality; stereotaxic techniques; essential tremor; Alzheimer’s disease; amyloid precursor protein; Tyr682 residue; YENPTY motif; Fyn tyrosine kinase; amyloid beta; ALS; biomarker; beta amyloid; AD; biomarkers; SARS-CoV-2; neuroinflammation; neurodegenerative nisease; nervous system; Alzheimer’s Disease; Vitamin D; 25(OH)D levels; biomarker; Vitamin D deficiency; biomarkers; inherited neuromuscular disorders; rare diseases; multiple sclerosis; genetic; polymorphisms; FOXP3; GATA3; vitamin D; magnetic resonance imaging; neuromelanin; nigrosome-1; iron; biomarkers; radiomics; neurodegenerative diseases; Parkinson’s disease; parkinsonian disorders; n/a